Phytosterols: From Preclinical Evidence to Potential Clinical Applications

Phytosterols (PSs) are plant-originated steroids. Over 250 PSs have been isolated, and each plant species contains a characteristic phytosterol composition. A wide number of studies have reported remarkable pharmacological effects of PSs, acting as chemopreventive, anti-inflammatory, antioxidant, an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in pharmacology 2021-01, Vol.11, p.599959
Hauptverfasser: Salehi, Bahare, Quispe, Cristina, Sharifi-Rad, Javad, Cruz-Martins, Natália, Nigam, Manisha, Mishra, Abhay Prakash, Konovalov, Dmitryi Alexeevich, Orobinskaya, Valeriya, Abu-Reidah, Ibrahim M, Zam, Wissam, Sharopov, Farukh, Venneri, Tommaso, Capasso, Raffaele, Kukula-Koch, Wirginia, Wawruszak, Anna, Koch, Wojciech
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Phytosterols (PSs) are plant-originated steroids. Over 250 PSs have been isolated, and each plant species contains a characteristic phytosterol composition. A wide number of studies have reported remarkable pharmacological effects of PSs, acting as chemopreventive, anti-inflammatory, antioxidant, antidiabetic, and antiatherosclerotic agents. However, PS bioavailability is a key issue, as it can be influenced by several factors (type, source, processing, preparation, delivery method, food matrix, dose, time of administration into the body, and genetic factors), and the existence of a close relationship between their chemical structures (e.g., saturation degree and side-chain length) and low absorption rates has been stated. In this sense, the present review intends to provide in-depth data on PS therapeutic potential for human health, also emphasizing their preclinical effects and bioavailability-related issues.
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2020.599959